Geode Capital Management, LLC Senti Biosciences, Inc. Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Senti Biosciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 245,590 shares of SNTI stock, worth $537,842. This represents 0.0% of its overall portfolio holdings.
Number of Shares
245,590
Previous 245,590
-0.0%
Holding current value
$537,842
Previous $93,000
26.88%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SNTI
# of Institutions
18Shares Held
8.79MCall Options Held
0Put Options Held
0-
Nea Management Company, LLC Timonium, MD4.43MShares$9.69 Million0.12% of portfolio
-
8 Vc Gp I, LLC Austin, TX2.54MShares$5.56 Million8.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA707KShares$1.55 Million0.0% of portfolio
-
Intel Corp Santa Clara, CA596KShares$1.3 Million0.12% of portfolio
-
Two Sigma Investments, LP New York, NY69.8KShares$152,7540.0% of portfolio
About Senti Biosciences, Inc.
- Ticker SNTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,757,100
- Market Cap $95.8M
- Description
- Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...